Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

New findings published in The Lancet Global Health expose substantial global and regional disparities in the cumulative burden of life-threatening maternal morbidity across the female reproductive life span.

Pregnant woman © StockSnap

The study, co-authored by researchers at the Leverhulme Centre for Demographic Science and London School of Hygiene & Tropical Medicine, is the first to calculate the lifetime risk of maternal near miss for 40 countries spanning Asia, Africa, the Middle East, and Latin America from 2010 onwards.

A ‘maternal near miss’ is defined as a woman who survived, but almost died from a life-threatening complication of pregnancy and childbirth. The World Health Organization (WHO) identifies cases of maternal near misses using clinical, laboratory, and lifesaving intervention-based criteria of organ dysfunction such as blood transfusion or emergency hysterectomy.

This novel study provides a cross-country comparison of the likelihood that a female individual aged 15 years will experience a maternal near miss before the age of 50, given the prevalence of maternal near miss morbidity, fertility, and mortality levels in each country for a specific year.

The lifetime risk of maternal near miss is one in 20 or higher in nine countries, seven of which are in sub-Saharan Africa. The highest risk is one in six in Guatemala (2016) which is almost 45 times higher than the lowest risk of one in 269 in Vietnam (2010).

 

Read the full story on the University of Oxford website.

 

Similar stories

KEMRI renews collaboration with Wellcome Trust and University of Oxford

The Kenya Medical Research Institute (KEMRI) has signed a seven-year Memorandum of Agreement with Wellcome Trust, a UK charitable organization, and the University of Oxford, on Wednesday 27 November 2024, at the KEMRI Headquarters, Nairobi. Under this collaboration, Wellcome has awarded GBP 91 million (KES 15 billion) to support research over the next 7 years.